反对堕胎的保守派人士在食品药品监督管理局（FDA）表示，在继续审查药物期间不会立即限制堕胎药米非司酮的获取渠道后，对特朗普政府发起了猛烈抨击。
Anti-abortion conservatives lashed out at the Trump administration after the Food and Drug Administration said it will not immediately limit access to the abortion pill mifepristone while it continues a review of the drug.
在周三晚间提交的一份长达五页、由法院命令提供的进展报告文件中，政府律师表示，官员们将继续收集有关米非司酮的数据直至12月，并预计将在3月前完成对结果的解读并起草报告。该文件指出，在完成上述步骤之前，该机构不会决定是否对米非司酮的药物安全计划作出调整——目前FDA允许该药物通过当面领取或邮寄方式提供，供女性在孕期数周内使用。
a five-page, court-ordered status update filed Wednesday night, the government’s lawyers said officials will keep collecting data on mifepristone through December, and they expect to interpret the results and draft a report by March. The filing says the agency will not decide whether to impose changes to its drug safety program for mifepristone — which the FDA currently allows to be dispensed in-person or by mail for use through weeks’ gestation — until after those steps are completed.
这份进展报告是路易斯安那州去年针对FDA提起诉讼的一部分，该诉讼旨在限制这种药物的获取渠道。报告发布后，反对通过远程医疗开具并邮寄该药物的反堕胎保守派人士感到愤怒。
The update, which came as part of a lawsuit the state of Louisiana brought against the FDA last year seeking to restrict access to the pill, angered anti-abortion conservatives who have been pushing for an end to the telehealth prescribing and mailing of the pills.
“行动生活”组织主席莉拉·罗斯称政府的这一时间表“不可接受”，并补充道：“FDA必须立即将堕胎药从市场上撤下。”
Lila Rose, president of the group Live Action, called the government’s timeline“UNACCEPTABLE,” adding, “The FDA must pull the abortion pill from the market NOW.”
“美国生命保护组织”主席玛乔丽·丹恩费勒称这份报告“令人担忧”，并表示该机构正在“试图兜售骗人的黄金”。
Marjorie Dannenfelser, president of SBA Pro-Life America, called the update “alarming” and said the agency is “trying to peddle fool’s gold.”
“学生生命组织”主席克里斯坦·霍金斯指责特朗普政府“拒绝在选举前发表任何言论”。这些谴责反映了反堕胎共和党人的日益不满，他们认为特朗普政府在第二个任期内尚未采取足够措施限制堕胎药的获取。
Kristan Hawkins, president of the group Students for Life, accused the Trump administration of “refusing to talk until after the election.”The condemnations were the latest example of frustrations from anti-abortion Republicans who believe the Trump administration has not done enough to restrict the availability of abortion pills in his second term.
已有100多项科学研究证实：米非司酮与米索前列醇联合使用可安全有效地终止妊娠，即便是通过线上处方并将药物邮寄给患者的形式也同样有效。然而，自2022年6月美国最高法院推翻“罗诉韦德案”裁决后，堕胎药的使用日益普及，反对堕胎的共和党人便不断施压，要求美国食品药品监督管理局重新评估该药物的可用性并限制其获取途径。
More than 100 scientific studies have confirmed mifepristone is safe and effective when used in conjunction with misoprostol to end a pregnancy, including when the pills are prescribed virtually and mailed to patients. But anti-abortion Republicans have been pushing for the FDA to review its availability and restrict access as the pills have become more popular after the Supreme Court overruled Roe v. Wade in June 2022.
据倡导堕胎权的“计划生育协会”统计，如今药物流产已占全美所有堕胎案例的大多数；通过邮寄方式获取堕胎药的比例也从2022年的5%上升至去年上半年的四分之一以上。
Medication abortions now account for the majority of abortions nationwide, and the use of abortion pills by mail has increased from accounting for 5% of all abortions in 2022 to more than a quarter in the first half of last year, according to data collected by the abortion rights advocacy group Society of Family Planning.
与此同时，民主党人及生殖权利倡导者指出，特朗普政府最新公布的时间表表明，其试图在中期选举前避免采取那些会引发政治争议的措施。上周，《华盛顿太阳报》报道称，白宫幕僚长苏西·怀尔斯及其他高级官员曾指示司法部长托德·布兰奇，在中期选举前切勿采取任何与堕胎相关的举措，不过白宫方面否认了这一报道。
Democrats and reproductive rights advocates, meanwhile, argued the Trump administration’s newly unveiled timeline suggests they are trying to dodge taking a politically unpopular action before the midterms. Last week, The Washington Sun reported that White House chief of staff Susie Wiles and other top officials directed Attorney General Todd Blanche to avoid any abortion-related actions before the midterms, though the White House denied the report.
尽管如此，民主党全国委员会于周四上午发布备忘录称，FDA周三提交的文件证明，政府正打算将“全面打击堕胎行为的行动”推迟到11月之后。
Nonetheless, the Democratic National Committee sent out a memo Thursday morning saying the Wednesday filing from the FDA proved that the government “is punting its full-scale attack on abortion” until after November.
“全民生殖自由”组织主席兼首席执行官米尼·蒂马拉朱表示，本届政府“正在推迟这份报告的发布，因为针对药物堕胎的攻击将在选民中适得其反，但极端分子会在选举一结束就试图禁止堕胎。”周三提交的文件还首次揭示了官员们如何进行这项审查——这一过程此前一直笼罩在保密之中。文件指出，官员们正在审查米非司酮在妊娠10周内终止妊娠的使用情况，涉及10万例病例，其中部分审查通过将药物堕胎与同期、同数量女性接受的手术堕胎进行比较来进行。
Mini Timmaraju, president and CEO of Reproductive Freedom for All, said the administration “is delaying this report because attacks on medication abortion will backfire with voters, but extremists will try to ban abortion as soon as the election is over.”The Wednesday filing also shed new light on how officials are conducting the review, a process that has otherwise been shrouded in secrecy. It states that officials are reviewing the use of mifepristone to end a pregnancy through 10 weeks’ gestation in 100,000 instances, in part by comparing it to surgical abortions during the same time frame and in the same number of women.
该文件称，安全性分析“将包括衡量多种安全结果的频率，并比较使用米非司酮的女性与对照组女性之间这些结果的频率，同时调整两组女性之间的基线差异。”尽管美国食品药品监督管理局（FDA）的审查仍在继续，但堕胎药仍面临其他威胁。布兰奇今年7月向参议院司法委员会表示，司法部官员将重新审议拜登政府司法部法律顾问办公室发布的一项意见。该意见认为，19世纪的《康斯托克法案》——一项反淫秽法律——无法被用来禁止邮寄堕胎药，这与反堕胎人士的主张相悖。
The filing states the safety analysis “will consist of measuring the frequency of a variety of safety outcomes and comparing the frequency of those outcomes between women who use mifepristone and the comparator group, adjusting for baseline differences in both groups of women.”While the FDA review remains ongoing, other threats to abortion pills loom. Blanche told the Senate Judiciary Committee in July that DOJ officials would review an opinion issued by the Biden DOJ’s Office of Legal Counsel that concluded the Comstock Act, a 19th-century anti-obscenity law, could not be invoked to ban the mailing of abortion pills, contrary to the wishes of abortion opponents.
本月早些时候，三个由共和党领导的州的总检察长向最高法院正式提出请求，要求起诉三个由民主党领导的州，理由是这些州的“保护法”阻止堕胎服务提供者被引渡至其他州并受到起诉。根据规定，当各州相互起诉时，最高法院拥有所谓的第一审管辖权，这意味着此类诉讼必须直接提交至最高法院，而非下级法院。然而，大法官们并无义务对此类案件作出裁决，而且历史上也极少这样做。
Earlier this month, attorneys general from three Republican-led states filed a formal request with the Supreme Court to sue three Democrat-led states over their shield laws preventing abortion providers from extradition and prosecution in other states. The high court has what’s known as original jurisdiction when states sue one another, meaning those suits are filed directly with the Supreme Court as opposed to a lower court. But the justices are not obligated to rule in such cases and have rarely done so.
同一天，路易斯安那州、阿肯色州和阿拉巴马州也向路易斯安那州西部地区法院提起诉讼，起诉了30多家堕胎药提供者，指控他们在受保密法保护的情况下运营，违反了联邦和州法律。
The same day, those states — Louisiana, Arkansas and Alabama — also filed a suit against more than 30 abortion pill providers in the Western District Court of Louisiana, alleging they are violating federal and state laws in operating under shield laws. The post Anti-abortion advocates fume after FDA declines to immediately impose abortion pill limits MS NOW